These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37123720)

  • 1. Hemolytic Disease of the Fetus and Newborn Due to Anti-Gonzales Antibody.
    Fives KR; Chism DA; Beetz B; Elkins I; Butala M
    Cureus; 2023 Mar; 15(3):e36860. PubMed ID: 37123720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
    Liu X; LE F; Wang LH; Shu J; Xu XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies.
    Varghese S; Prakash S; Mukherjee S; Sahu A; Mishra D
    Asian J Transfus Sci; 2023; 17(2):291-294. PubMed ID: 38274971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical model for prediction of ABO hemolytic disease of the fetus and newborn in India.
    Patale DS; Lokhande TL; Chaudhary RK
    Immunohematology; 2021 Jun; 37(2):64-68. PubMed ID: 34170645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    He Y; Gao W; Li Y; Xu C; Wang Q
    Transfusion; 2023 Mar; 63(3):494-506. PubMed ID: 36727659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
    Ayenew AA
    Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic disease of the fetus and newborn mediated by anti-Di
    Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
    Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen.
    Páez M; Jiménez M; Corredor A
    Biomedica; 2021 Dec; 41(4):643-650. PubMed ID: 34936250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal-maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature.
    Neamţu SD; Novac MB; Neamţu AV; Stanca ID; Boldeanu MV; Gluhovschi A; Stanca L; Dijmărescu AL; Manolea MM; Trăistaru MR; Mateescu GO; Siminel MA
    Rom J Morphol Embryol; 2022; 63(1):229-235. PubMed ID: 36074689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
    Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
    Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
    Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
    Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.